Inhibikase Therapeutics, Inc. (IKT) Insider Trading

Name: Inhibikase Therapeutics, Inc. (IKT) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 31, 2026): RA CAPITAL MANAGEMENT, L.P. (10% Owner): Other (see footnotes) of 18,030,000 shares.

Get alerted when insiders trade IKT

Email address

Loading company data...

Beta

Loading company details...

Beta